[HTML][HTML] NAFLD: a multisystem disease

CD Byrne, G Targher - Journal of hepatology, 2015 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in Western countries that is predicted to become also the most frequent indication for liver …

MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice

PS Dulai, CB Sirlin, R Loomba - Journal of hepatology, 2016 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of
chronic liver disease, and its prevalence is rising worldwide. The occurrence of non …

Quantification of liver fat content with ultrasound: a WFUMB position paper

G Ferraioli, A Berzigotti, RG Barr, BI Choi… - Ultrasound in medicine …, 2021 - Elsevier
New ultrasound methods that can be used to quantitatively assess liver fat content have
recently been developed. These quantitative ultrasound (QUS) methods are based on the …

Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial

HJ Zhang, J He, LL Pan, ZM Ma, CK Han… - JAMA internal …, 2016 - jamanetwork.com
Importance Nonalcoholic fatty liver disease (NAFLD) is a prevalent risk factor for chronic
liver disease and cardiovascular disease. Objective To compare the effects of moderate and …

Accuracy of liver fat quantification with advanced CT, MRI, and ultrasound techniques: prospective comparison with MR spectroscopy

H Kramer, PJ Pickhardt, MA Kliewer… - American journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to prospectively evaluate the accuracy of proton-
density fat-fraction, single-and dual-energy CT (SECT and DECT), gray-scale ultrasound …

NAFLD and thyroid function: pathophysiological and therapeutic considerations

E Hatziagelaki, SA Paschou, M Schön… - Trends in Endocrinology …, 2022 - cell.com
Nonalcoholic fatty liver disease (NAFLD) is a worldwide rising challenge because of hepatic,
but also extrahepatic, complications. Thyroid hormones are master regulators of energy and …

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

C Moreno, S Mueller, G Szabo - Journal of hepatology, 2019 - Elsevier
Even though alcohol-related liver disease (ALD) is a major cause of severe liver disease
worldwide, most patients with ALD are diagnosed at the decompensation stage. Liver biopsy …

[HTML][HTML] Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions

A Ofosu, D Ramai, M Reddy - Annals of gastroenterology, 2018 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) affects over 30% of the United States population
and is projected to become a leading cause of chronic liver disease by 2020. As a result, the …

Diagnostic modalities of non-alcoholic fatty liver disease: from biochemical biomarkers to multi-omics non-invasive approaches

E Martinou, M Pericleous, I Stefanova, V Kaur… - Diagnostics, 2022 - mdpi.com
Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic
liver disease worldwide, and its prevalence is increasing globally. NAFLD is a multifaceted …

[HTML][HTML] Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

DH Lee - Clinical and molecular hepatology, 2017 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) has been an emerging major health problem, and
the most common cause of chronic liver disease in Western countries. Traditionally, liver …